Presenter's Information

Horst Sievert, MD

Country Germany
Specialty Interventional Cardiologist
  1. Carotid Stenting with Proximal Protection in All-comer Patients
  2. Endovascular Papillary Muscle Approximation: A Novel Approach for Heart Failure Treatment
  3. Selected New LAA Closure Techniques and Devices
  4. Innovations in Transcatheter Tricuspid Valve Interventions: What is Coming?
  5. Current Status of TAVR - What We Have Achieved?
  6. The REDUCE-FMR Trial
  7. The Big Picture: Choosing the Right Device for the Right Anatomy
  8. REDUCE-FMR
  9. TAVR Outcome of Venus and Venibri Valves
  10. Complication During Mitral Valve Intervention
  11. Patient and Device Selection for ViV TAVR: The Good, the Bad, and the Ugly
  12. MV and TV Intervention: Current Status and Future Perspectives
  13. Severe Secondary MR: Medical Treatment vs. Surgery vs. Intervention
  14. Where to with Cerebral Protection in TAVI?
  15. Micromesh Technology in Carotid Stents: Soft vs. Hard Landing
  16. Transcatheter Tricuspid Valve Repair
  17. Carotid Artery Stenosis: Optimal Candidate for Revascularization
  18. [Invited Case Presentation & Focus Review] TAVI: That Should Not Be too Difficult.
  19. TAVR for Low Risk and Younger Patients
  20. Severe Asymptomatic Aortic Stenosis
  21. Initial Experience with a Bioresorbable ASD/PFO Occluder
  22. Current Procedural Recommendations of Renal Denervation in 2016
  23. Transcatheter Mitral Valve Replacement Beyond Repair: New Paradigm Changes or Not Yet?
  24. Renal Denervation and Treatment of Hypertension: Clinical Update
  25. Practical Question: How We Should Define \"Responsiveness\" to Renal Denervation - HTN and Beyond HTN Indications
  26. Should PFOs Be Closed?
  27. Clinical Data and Guidelines Update; From Clinical Trial to Real-world Registry
  28. Clinical Trials for PFO Closure: Lessons Learnt and Future Perspectives
  29. Challenging Anatomies and Situations
  30. Devices and Long-term Outcomes of Renal Denervation for Hypertension
  31. To Closure or Not to Closure(LAA Closure & PFO Closure)
  32. Place of LAAC in the Era of New OATs
  33. Transcatheter Renal Denervation Therapy: A Breakthrough for Refractory Hypertension?
  34. LAA Closure with the Watchman versus Amplatzer Cardiac Plug
  35. Acute and Chronic Complications in ASD Closure
  36. Which System Is better?: Watchman or Cardiac Plug or Something
  37. What We\'ve Learned from Simplicity HTN-1,2, and Registries
  38. Transcatheter Renal Denervation for Refractory Hypertension: Current Understanding and Future Projections
  39. Left Atrial Appendage Closure - State of the Art
  40. Percutaneous LAA Closure: A Future Management Alternative for Stroke Prevention in AF Patients
  41. New Directions- Structural Heart Disease Intervention
  42. Update on Percutaneous PFO Closure
Conference Slides
Category